BibTex RIS Cite

Nabilon: Anti-emetik Etkili Cannabinoid

Year 1985, Volume: 1 Issue: 1-2, 107 - 110, 17.02.2015

Solmaz Doğanca

https://izlik.org/JA52LF49JZ

Abstract

Keywords

-

There are 0 citations in total.

Details

Primary Language English
Authors

Solmaz Doğanca This is me

Publication Date February 17, 2015
DOI https://doi.org/10.12991/mpj.45744
IZ https://izlik.org/JA52LF49JZ
Published in Issue Year 1985 Volume: 1 Issue: 1-2

Cite

APA Doğanca, S. (2015). Nabilon: Anti-emetik Etkili Cannabinoid. Marmara Pharmaceutical Journal, 1(1-2), 107-110. https://doi.org/10.12991/mpj.45744
AMA 1.Doğanca S. Nabilon: Anti-emetik Etkili Cannabinoid. J Res Pharm. 2015;1(1-2):107-110. doi:10.12991/mpj.45744
Chicago Doğanca, Solmaz. 2015. “Nabilon: Anti-Emetik Etkili Cannabinoid”. Marmara Pharmaceutical Journal 1 (1-2): 107-10. https://doi.org/10.12991/mpj.45744.
EndNote Doğanca S (February 1, 2015) Nabilon: Anti-emetik Etkili Cannabinoid. Marmara Pharmaceutical Journal 1 1-2 107–110.
IEEE [1]S. Doğanca, “Nabilon: Anti-emetik Etkili Cannabinoid”, J Res Pharm, vol. 1, no. 1-2, pp. 107–110, Feb. 2015, doi: 10.12991/mpj.45744.
ISNAD Doğanca, Solmaz. “Nabilon: Anti-Emetik Etkili Cannabinoid”. Marmara Pharmaceutical Journal 1/1-2 (February 1, 2015): 107-110. https://doi.org/10.12991/mpj.45744.
JAMA 1.Doğanca S. Nabilon: Anti-emetik Etkili Cannabinoid. J Res Pharm. 2015;1:107–110.
MLA Doğanca, Solmaz. “Nabilon: Anti-Emetik Etkili Cannabinoid”. Marmara Pharmaceutical Journal, vol. 1, no. 1-2, Feb. 2015, pp. 107-10, doi:10.12991/mpj.45744.
Vancouver 1.Solmaz Doğanca. Nabilon: Anti-emetik Etkili Cannabinoid. J Res Pharm. 2015 Feb. 1;1(1-2):107-10. doi:10.12991/mpj.45744

.